CardiAQ Valve Technologies Company Profile

09:50 EST 22nd November 2017 | BioPortfolio

Privately held CVT, headquartered in Irvine, Calif., has developed a proprietary system for Transcatheter Mitral Valve Implantation (TMVI). Through the combination of a unique anchoring mechanism and a novel delivery catheter, physicians will be able to accurately and securely implant a new mitral valve within a beating heart, thus avoiding open-heart surgery. The CVT procedure is designed to be performed in a cardiac catheterization laboratory similar to angioplasty or stenting, resulting in less trauma to the patient and substantial cost-savings to the healthcare system.

News Articles [442 Associated News Articles listed on BioPortfolio]

FDA Approves New 'Resilient' Inspiris Heart Valve

The valve is currently surgically implanted, but designed with an eye for future valve-in-valve procedures. FDA Approvals

Heart valve replacement success may depend on age, valve type

(Reuters Health) - People who need a heart valve replaced often face a dilemma: should they have a mechanical valve made of graphite or a biological valve derived from a cow or pig? A new study sugges...

Surgical Pericardial Valve Treats Aortic Valve Disease

A new bioprosthetic valve (BHV) provides innovative features designed to enhance clinical performance during aortic valve replacement.

CoreMedic secures capital for heart-valve repair technologies

SHS Gesellschaft fur Beteiligungsmanagement invested an undisclosed amount in CoreMedic, a heart valve-repair startup based i -More- 

Looking to the Future of Mitral Valve Replacement

Is transapical transcatheter mitral valve implantation poised to become an alternative solution for patients with mitral valve disease? European Heart Journal

Medical News Today: Mitral valve prolapse: What you need to know

Mitral valve prolapse is a condition where a valve in the heart stops working normally. Learn what causes it, how it is diagnosed, and how it is treated.

Expanded Use for Heart Valve

An expanded indication for the Sapien 3 transcatheter heart valve (THV) will enable certain patients with a failed bioprosthetic aortic or mitral valve to avoid potential complications from repeat ope...

Neovasc grosses $32.8mm via private placement

Neovasc Inc. (cardiovascular devices) completed a private placement of $32.8mm aggregate principal amount of senior secured convertible notes and Series E warrants to purchase one common share. The 18...

PubMed Articles [1073 Associated PubMed Articles listed on BioPortfolio]

Transcatheter Aortic Valve Replacement for Perceval Sutureless Aortic Valve Failure.

As experience with Perceval aortic prosthesis and valve-in-valve TAVR grows, it will be crucial to meticulously document short- and long-term follow-up for establishment of real-world safety and durab...

Acute Obstructive Thrombosis of Sapien 3 Valve After Valve-in-Valve Transcatheter Aortic Valve Replacement for Degenerated Mosaic 21 Valve.

Carcinoid Valve Disease: A Case Report and Review.

In patients with carcinoid syndrome, the development of carcinoid valve disease typically carries an unfavorable prognosis. We present the case of a patient with significant valvular dysfunction secon...

Transcatheter Tricuspid Valve-In-Valve Implantation in Patients with Tricuspid Bioprosthetic Valve Degeneration at High Surgical Risk: A Multicenter Case Series.

Transcatheter tricuspid valve-in-valve implantation (TVIV) is an attractive yet under-explored alternative to redo valve surgery.

Aortic sinus flow stasis likely in valve-in-valve transcatheter aortic valve implantation.

Valve-in-valve procedures using transcatheter aortic valves are increasingly performed to treat degenerated bioprosthetic surgical aortic valves because they are less invasive than redo aortic valve r...

Clinical Trials [855 Associated Clinical Trials listed on BioPortfolio]

CardiAQ-Edwards™ Transcatheter Mitral Valve Replacement (TMVR) Study

Clinical study to evaluate the safety and performance of the CardiAQ-Edwards™ Transcatheter Mitral Valve

A Clinical Study of the CardiAQ™ TMVI System (Transapical DS)

The purpose of the study is to evaluate the initial short and long-term safety and performance of the CardiAQ™ Transcatheter Mitral Valve Implantation System using the Transapical Delive...

Early Feasibility Study of the CardiAQ™ TMVI System (Transfemoral and Transapical DS)

The purpose of the study is to generate early US feasibility data of the CardiAQ™ Transcatheter Mitral Valve Implant System. The study will enroll patients with moderate to severe mitra...

Edwards Lifesciences CardiAQ™ Transcatheter Mitral Valve Replacement (TMVR) Early Feasibility Study

Early feasibility study to evaluate the safety and function of the Edwards Lifesciences CardiAQ™ Transcatheter Mitral Valve

Balloon Aortic Valvuloplasty During Surgical Aortic Valve Replacement

Prospective, two academic center, non-randomized pilot, acute in-patient study correlating pre-operative imaging studies, intra-operative measurements and intra-operative balloon aortic va...

Companies [1284 Associated Companies listed on BioPortfolio]

CardiAQ Valve Technologies, Inc.

Privately held CardiAQ, headquartered in Irvine, Calif., has developed a proprietary Transcatheter Mitral Valve (TMV) Implant that can be delivered through multiple delivery syste...

CardiAQ Valve Technologies Inc.

CardiAQ Valve Technologies

Privately held CVT, headquartered in Irvine, Calif., has developed a proprietary system for Transcatheter Mitral Valve Implantation (TMVI). Through the combination of a unique anc...

Transcatheter Technologies GmbH

Transcatheter Technologies GmbH is a privately held medical device company, founded in January 2009, and headquartered in Regensburg, Germany. The Trinity transapical aortic valve system's valve p...

BioStable Science & Engineering, Inc.

BioStable Science & Engineering is a cardiovascular device company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to v...

More Information about "CardiAQ Valve Technologies" on BioPortfolio

We have published hundreds of CardiAQ Valve Technologies news stories on BioPortfolio along with dozens of CardiAQ Valve Technologies Clinical Trials and PubMed Articles about CardiAQ Valve Technologies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CardiAQ Valve Technologies Companies in our database. You can also find out about relevant CardiAQ Valve Technologies Drugs and Medications on this site too.

Quick Search

Relevant Topics

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Corporate Database Quicklinks

Searches Linking to this Company Record